UBS Maintains Impinj at Neutral, Raises Price Target to $180
UBS raised its Impinj price target from $175 to $180 while maintaining a Neutral rating.
Related stories
DaVita Repurchased 382,563 Shares From Berkshire Hathaway
SEC filings show Berkshire Hathaway still owned about 28.3 million DaVita shares following the repurchase.
M impact | EQUITY | Oct 29, 2026, 09:45 PM UTC
Origin Energy Reports 34.2% Sequential Rise in First-Quarter APLNG Revenue
Origin Energy said revenue from its stake in the Australia Pacific LNG project rose 34.2% sequentially in the first quarter, supported by higher realised oil prices on LNG sales.
H impact | EQUITY | Oct 29, 2026, 09:42 PM UTC
Dexcom Reports Third-Quarter Revenue of $1.34 Billion
Dexcom reported third-quarter 2026 revenue of $1.34 billion, up 11.2% year over year. Net income fell 3.1% to $275.1 million, while diluted EPS rose 2.9% to $0.72.
M impact | EQUITY | Oct 29, 2026, 09:31 PM UTC
Starbucks Shares Dip 3% After Hours as China Restructuring Weighs on Q4 Revenue
Starbucks said fourth-quarter revenue dipped amid China restructuring efforts, while same-store sales and profits strengthened. Shares fell 3% after hours on Thursday.
M impact | EQUITY | Oct 29, 2026, 09:30 PM UTC
Intel CFO Expects CCPG Revenue to Fall More Than 20% Sequentially in Q4
M impact | EQUITY | Oct 29, 2026, 09:30 PM UTC
Intel CFO Sees Server CPU Unit Growth Above 30% in 2026 and 2027
Intel’s CFO sees industry server CPU unit growth of more than 30% in both 2026 and 2027.
H impact | EQUITY | Oct 29, 2026, 09:29 PM UTC